• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Tissium's COAPTIUM Connect Achieves Successful Nerve Repair in Australia

    ABB Robots Automate COVID-19 Neutralizing Antibody Test

    Sensydia Achieves Study Target for Heart-Sound AI

    Teleflex to Expand Facility in Jaffrey, New Hampshire

    TransMed7's Concorde Soft Tissue Biopsy Devices Used in First Clinical Cases
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Timeline Mystery for Updated EtO Rules

    An Update on Hospital Trends Post-Pandemic

    Don’t Fear the Audit: Benefits of Good Quality Practices

    Understanding the FDA’s Standards & Conformity Assessment Program

    Medtech Divestitures Are Good for Medtech Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Fusion Biotec Inc.

    NDH Medical Inc.

    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Designing for Manufacturing: 5 Common Startup Mistakes (and How to Avoid Them)

    5 Challenges Medtech Must Address to Transform Healthcare

    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Fusion Biotec Inc.

    NDH Medical Inc.

    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Smart Devices and Drug Formulations: Trends Affecting the Combination Products Market

    An interview with Gilero's CEO Ted Mosler analyzes the diverse drug delivery/combination products market.

    Smart Devices and Drug Formulations: Trends Affecting the Combination Products Market
    Sam Brusco, Associate Editor11.15.19
    The drug delivery and combination products market is made up of a number of markets, all based on the means by which the drug is delivered. Some are administered through injection, some through infusion, some orally, some transdermally, and the list continues. Nanomedicine and nano delivery systems are emerging as a method of targeted drug delivery, in which particles attracted to diseases cells directly treat those cells. Implant technology can also deliver targeted medication, providing longer-lasting, localized therapy.
     
    In order to gain more insights about the trends and challenges affecting the diverse drug delivery and combination products markets, I spoke to Ted Mosler, CEO of Gilero, a Morrisville, N.C.-based single-source partner for design, development, and manufacturing in the medical and drug delivery markets. A portion of his input was included in the November/December issue feature article “Delivering the Goods: The Evolving World of Combination Products.” The entirety of our interview is featured here.
     
    Sam Brusco: What were the trends that drove the biopharma and drug delivery/combination product markets in 2019?
     
    Ted Mosler: Over the past year we’ve noticed trends in smart devices, non-clinical use of medical devices and an increased need for safety and overall ease of use. Smart devices are being used to drive medication compliance and share patient data with healthcare providers. In addition to smart devices being put into the hands of patients and caregivers, there are also growing numbers of non-clinician device users such as patients self-administering injectable medications at home. These trends call for drug delivery devices and combination products to be intuitive, easy to use and safe to operate for individuals without medical training.
     
    Brusco: Which latest developments and/or innovations in drug delivery technology/combination products have captured your attention?

    Mosler: Mobile apps becoming medical devices is something that has really piqued our interest. Gilero has had the opportunity to work on some of these projects, and it is inspiring to see the ways in which technology can put more tools into the hands of users to help them manage their health. One of the biggest challenges with apps as medical devices is how to regulate them, and it will be interesting to see how this technology evolves in the medical device and drug delivery markets over the next few years.
     
    Brusco: What effect is the convergence of pharma and medtech having on the medical device industry?
     
    Mosler: More unique drug formulations are being developed and we are seeing a rise in unique devices used to access and deliver these drugs. Customers working on chemotherapy drug delivery, inhaled medications and ophthalmic solutions have asked us to design and develop entire medical devices around a specific drug. As drugs become more potent and we learn more about the risks of addiction, there is an even greater need for increased safety. Innovative device solutions can play a huge role in ensuring successful drug delivery while keeping patients and caregivers safe.
     
    Brusco: How does the approach to designing, manufacturing, and/or testing a drug delivery device/combination product (or components that go into these devices) differ from other medtech products?
     
    Mosler: Other medtech products do not have the same complexities of FDA regulations that pharmaceutical products do. The pathways of demonstrating safety and effectiveness of drug delivery devices and combination products vary a great deal.  Depending how the drug is prescribed and delivered, non-clinical users of the device often come into play. This is when human factors becomes an even more important step in the development process. Gilero has seen an increase in customers inquiring about human factors services like user research, formative studies and summative studies. Our in-house human factors group has been increasingly busy with studies for prefilled syringes, needle safety devices and other drug delivery products.
     
    Brusco: What are the challenges and opportunities for drug delivery and combination products in the next few years?
     
    Mosler: We are finding that the regulatory changes in Europe are making the launch of new devices in the European market extremely challenging. In the US, there is a real possibility of the transition to a single-payer healthcare system. This means we need to reduce the cost of drug delivery and combination products without compromising product effectiveness or safety. Finding opportunities to reduce cost while improving the overall health and wellbeing of patient populations is a challenging dichotomy. The projects we work on with the best market outlook appear to do both.
     
    Brusco: Is there anything else you’d like to say regarding the manufacturing of drug delivery/combination products or components?
     
    Mosler: At Gilero, we have seen an overall increase in the demand for self-administered medications, combination products and advanced safety solutions that make drug delivery safer and easier for everyone involved. We believe this demand is only going to grow and we are expanding our offerings to keep up with it.
    Related Searches
    • health
    • medical device
    • compliance
    • mpo
    Related Knowledge Center
    • Software & IT
    • Electronics
    Suggested For You
    CE Mark Granted to Expandable, Biodegradable Biliary Stent CE Mark Granted to Expandable, Biodegradable Biliary Stent
    Smaller Devices Require More Efficient Material Integration Smaller Devices Require More Efficient Material Integration
    Phillips-Medisize Unveils Aria Smart Autoinjector Platform Phillips-Medisize Unveils Aria Smart Autoinjector Platform
    EAG Expands Medical Device Testing Services With New Lab EAG Expands Medical Device Testing Services With New Lab
    FDA Making Progress With Technology and Data Action Plans FDA Making Progress With Technology and Data Action Plans
    OrthogenRx on FDA’s Ambiguity on Hyaluronic Acid OrthogenRx on FDA’s Ambiguity on Hyaluronic Acid
    New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    Gilero Gilero
    Pharmaceutical Focus: A Look at Combination Products Pharmaceutical Focus: A Look at Combination Products
    Engineering and Manufacturing Partnerships: The Key to Successful Combination Products Engineering and Manufacturing Partnerships: The Key to Successful Combination Products
    Combination Products Update—Mike on Medtech Combination Products Update—Mike on Medtech
    The Medtech Supply Chain and COVID-19 The Medtech Supply Chain and COVID-19
    Novel Polymers for Sustained Release: Trends Impacting the Drug Delivery Market Novel Polymers for Sustained Release: Trends Impacting the Drug Delivery Market
    The Special 510(k) Program—Mike on Medtech The Special 510(k) Program—Mike on Medtech
    Anaconda Biomed Completes First-in-Human Study of Thrombectomy System Anaconda Biomed Completes First-in-Human Study of Thrombectomy System

    Related Breaking News

    • CE Mark Granted to Expandable, Biodegradable Biliary Stent

      CE Mark Granted to Expandable, Biodegradable Biliary Stent

      The UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent is intended to facilitate the drainage of obstructed ducts requiring larger openings.
      PR Newswire 09.07.21

    • Materials
      Smaller Devices Require More Efficient Material Integration

      Smaller Devices Require More Efficient Material Integration

      Silicones are becoming increasingly well-suited for implantable medical devices and combination products.
      Michael Barbella, Managing Editor 08.03.21

    • Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Small and easy-to-use injection device is designed to support medication management.
      Phillips-Medisize 08.02.21


    • Testing
      EAG Expands Medical Device Testing Services With New Lab

      EAG Expands Medical Device Testing Services With New Lab

      The laboratory includes a dedicated medical device polymer analysis area.
      Business Wire 07.12.21

    • FDA Making Progress With Technology and Data Action Plans

      FDA Making Progress With Technology and Data Action Plans

      There is an urgent need to get advanced technologies into the healthcare ecosystem, but all products must first get regulatory approval.
      Alan Rencher, Vice President, Engineering, MasterControl 03.04.21

    Loading, Please Wait..

    Breaking News
    • Tissium's COAPTIUM Connect Achieves Successful Nerve Repair in Australia
    • ABB Robots Automate COVID-19 Neutralizing Antibody Test
    • Sensydia Achieves Study Target for Heart-Sound AI
    • Canadian Health System Evaluating Abdominal Wound Closure Tech
    • Teleflex to Expand Facility in Jaffrey, New Hampshire
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Jiaherb Receives CITES Certification for Rhodiola Rosea
    Hyaluronic Acid Ingredient Linked to Antioxidant Benefits In Vitro
    Anita Johansen Appointed New CEO of Probi
    Coatings World

    Latest Breaking News From Coatings World

    BASF’s Monomers Division Receive ISCC+ Certification in Its Two Asian Production Sites
    Omya to Represent Songwon’s Coatings Portfolio in 4 South-Asian Countries
    Brenntag Commences Operations at Its New Site in Zhangjiagang, China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    ABB Robots Automate COVID-19 Neutralizing Antibody Test
    Sensydia Achieves Study Target for Heart-Sound AI
    Canadian Health System Evaluating Abdominal Wound Closure Tech
    Contract Pharma

    Latest Breaking News From Contract Pharma

    GSK, Scynexis Partner to Develop Brexafemme for Drug-Resistant Fungal Infections
    Mytide Names Martina Diekmann CEO
    Quotient Sciences Supports Crinetics Pharma with Pediatric Development, Clinical Testing Program
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Venus Launches Dermaplaning Skincare Regimen
    Olberding Brand Family Updates Leadership Team and Expands Capabilities
    Rimmel London Chooses Maya Jama as the New Face of the Brand
    Happi

    Latest Breaking News From Happi

    Coty Appoints Caroline Andreotti as Chief Commercial Officer, Prestige
    Gillette Venus Launches First Ever Dermaplaning Skincare Collection
    L'Oréal Canada Implements L'Oréal's Product Impact Labeling System
    Ink World

    Latest Breaking News From Ink World

    ACTEGA to Showcase Products and Solutions at Interpack 2023
    hubergroup Print Solutions Takes Stock of Digital Print Folders
    INX International Makes Investment in Gooten
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    CUPSZ chooses Mark Andy Evolution Series E5
    Registration opens for RadTech Europe webinar series
    Beontag moves up on list of Fastest Growing Companies 2023
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Binder Unveils New Look, Website
    Drylock Technologies Plants First Trees in Drylock Forest
    A.Celli Group to Hold Open House
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    European Innovation Council Awards Grant for Brain-Computer Interface Tech
    Report: No Complications With OssDsign Catalyst Graft
    FDA OKs Bioretec's RemeOs Bioresorbable Metal Trauma Screw
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Emerson Named 2023 ENERGY STAR Partner of the Year
    Nano Dimension Increases Offer to Acquire Stratasys to $19.55 Per Share in Cash
    Universal Display Sponsors, Presents at ICDT 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login